The detection of age-, gender-, and region-specific changes in mouse brain tocopherol levels via the application of different validated HPLC methods by Nánási, Nikolett et al.
 1 
 
The detection of age-, gender-, and region-specific changes in mouse 
brain tocopherol levels via the application of different validated 
HPLC methods 
 
Authors: Nikolett Nánási1, Gábor Veres1,2, Edina K. Cseh1, Márton Szentirmai1, Diána Martos1, 
Evelin Sümegi1, Levente Hadady1, Péter Klivényi1, László Vécsei1,2, Dénes Zádori1* 
 
Affiliations: 
1Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University 
of Szeged, Szeged, Hungary 
2MTA-SZTE Neuroscience Research Group, Szeged, Hungary 
 
*Corresponding author: 
Dénes Zádori MD, PhD 
Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University 
of Szeged 
Semmelweis u. 6, H-6725 Szeged, Hungary 
Phone: +36 62 545351 
Fax: +36 62 545597 
E-mail: zadori.denes@med.u-szeged.hu
 2 
 
 
Abstract 
 
The aging process clearly increases the demand for antioxidant protection, especially in the brain, 
involving that provided by α-tocopherol (αT). However, little is known about the age-related 
changes in brain αT levels and the influencing effect of gender on it, in human or murine samples as 
well. Accordingly, the aim of the current study was to detect age-, gender- and region-specific 
changes in αT concentrations in mouse brain tissue and to assess the influencing effect of plasma 
αT levels on it. 
Female and male C57BL/6 mice at the ages of 6, 16 and 66 weeks (n = 9 in each group) were 
applied. αT levels were determined with high performance liquid chromatography (HPLC) from the 
striatum, cortex, hippocampus, cerebellum, brainstem and from plasma samples. A detailed 
validation process was carried out for the applied HPLC method as well. 
The results demonstrated that brain αT levels significantly increased in the striatum, cortex, and 
hippocampus with aging in both genders, but in a more pronounced way in females with an 
increasing magnitude of this difference. In case of the cerebellum, a moderate elevation could be 
detected only in females, whereas in case of the brainstem there was no significant change in αT 
level. With regard to plasma samples, no clear trend could be identified. 
The current study is the first to present age-dependent gender-specific changes in αT level in certain 
brain regions of the C57Bl/6 mouse strain, and may provide meaningful information for future 
therapeutic studies targeting aging-related processes. 
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1. Introduction 
 
Tocopherols and tocotrienols, also known as the fat-soluble vitamin E, have an outstanding role in 
antioxidant mechanisms [1, 2]. This antioxidant protection may have a special relevance with 
regard to the brain, which organ is especially prone to oxidative injuries due to its high energy 
demand and elevated lipid content [3]. Accordingly, the deficiency of vitamin E often causes 
neurological symptoms and studies have proved significantly lower serum or plasma α-tocopherol 
levels in some neurological disorders, such as in Alzheimer’s disease (AD) [4, 5] and in Parkinson’s 
disease (PD) [6], which have an increasing prevalence in the elderly, and in some other neurological 
conditions [7–11]. 
With regard to the effects of normal aging on serum tocopherol levels, studies have shown a trend 
of similarly increasing concentrations in both gender [12, 13] which may be the consequence of the 
age-related alteration in lipid homeostasis [14]. Studies investigated α-tocopherol (αT) level in 
cerebrospinal fluid (CSF) in healthy subjects [15] and in patients with Alzheimer-type dementia 
(ATD) [16] as well. In addition to the delineation of positive correlations between serum and CSF 
αT and γ-tocopherol (γT) levels in the healthy ones, significantly decreased CSF αT level was 
demonstrated in ATD compared to controls. In relation to human brain tocopherol levels, studies 
provided contradictory results. Craft et al. [17] carried out an examination on the regional 
distribution of the level of αT and γT isomers, demonstrating significant age-related (67-90 years, n 
= 5 – 2 females and 3 males) decline in αT level, more pronounced in females, but due to low case 
number, statistical comparison could not be carried out. With regard to the regional distribution, 
there were no significant differences between the grey and white matter of frontal and occipital 
cortices. Later, Johnson et al. [18] demonstrated a significant relationship between cognitive 
functions and tocopherol levels in the serum, cerebellar, frontal, occipital, and temporal cortices of 
healthy octogenarians and centenarians. In case of serum samples, dramatically lower 
concentrations were measured, whereas for given brain regions, significantly higher levels were 
determined with aging. There was a significantly negative correlation between serum and brain αT 
levels, except the cerebellum, although cerebellar αT level, similarly to that of the other brain 
regions, also positively correlated with the scores of Mini-Mental State Examination (MMSE) and 
Severe Impairment Battery (SIB), both of which are measures of global cognition. 
With regard to rodent studies on tocopherol homeostasis, only limited data are available about the 
effect of aging and gender on plasma or serum and brain tocopherol levels. Most of the available 
rodent tocopherol studies did not separate animals to the necessary groups for later statistical 
comparisons [19–26]. Although Gohil et al. [27] determined αT level in several brain regions 
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(cerebral cortex, hippocampus, cerebellum, midbrain and the remaining part of the brainstem) of 5 
months old C57Bl/6 female (n = 5) and male (n = 3) mice and found significantly higher αT 
concentrations in all the five regions in females than in males, moreover significantly lower αT 
level was observed in the cerebellum than those of other examined brain regions, no information 
was obtained about the effect of aging. With regard to cholesterol levels, there was not any 
significant difference between genders. There is only one study [28] which assessed the effect of 
aging on tocopherol levels of rodents in details and reported a not significant decrease in plasma αT 
level (from ~ 8 to ~ 6 µM) with aging in C57Bl/6NCr male mice (3, 6, 12, 18 and 24 months old, n 
= 5) and significantly increasing values only in some brain regions (cerebrum (from 10 to 20 
nmol/g tissue), hippocampus (from 12 to 25 nmol/g tissue) and cerebellum (from 11 to 15 nmol/g 
tissue)). In addition, it was also demonstrated that triglyceride levels were not influenced by aging. 
However, female mice were not utilized in this study, so the effect of gender cannot be assessed. 
There are many available detection methods for the measurement of tocopherol concentrations from 
plasma or serum and from brain samples [29]. Accordingly, Vitamin E compounds are mainly 
assessed by diode-array detector (DAD) [30], electrochemical detector (ECD) [31], fluorescence 
detector (FLD) [32] or mass spectrometry [22, 33]. In case of plasma or serum and brain samples of 
rodents, especially those of mice, the measurements of other tocopherols are challenging because of 
their small concentration levels. For the determination of their levels, more sensitive methods are 
necessary, because with the application of ECD, FLD and DAD, usually only αT can be measured 
reliably [29]. 
The aim of the current study was the expansion of the research of Takahashi et. al. [28] and Gohil 
et. al [27] to be able to quickly and reliably determine αT concentrations in mouse plasma and brain 
tissues searching for the influencing effects of gender and aging via the application of robust, 
reproducible and validated HPLC methods. As a part of this process, the applicability of FLD and 
ECD detectors for the measurement of αT from brain samples was investigated as well. 
 
2. Materials and methods 
 
2.1. Materials 
αT, ammonium acetate, ascorbic acid, butylated hydroxytoluene (BHT), dioxane, n-hexane, 
methanol (MeOH), ethylenediaminetetraacetic acid (EDTA) and sodium-perchlorate (NaClO4) were 
purchased from Sigma-Aldrich (Saint Louis, MO, USA). Rac-tocol (rT) was acquired from Matreya 
LLC (Pleasant Gap, PA, USA). 
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Acetonitrile (ACN), tetrahydrofuran (THF), absolute ethanol (EtOH), isopropanol (IPA), sodium-
chloride (NaCl), disodium-hydrogen-phosphate hydrate (Na2HPO4*2 H2O) and sodium-hydrogen-
carbonate (NaHCO3) were purchased from VWR International (Radnar, PA, USA). 
Potassium-dihydrogen-phosphate (KH2PO4), sodium-dihydrogen-phosphate (NaH2PO4), D-glucose 
hydrate (D-glucose*1 H2O) and calcium-chloride hydrate (CaCl2*2 H2O) were obtained from 
Reanal (Budapest, Hungary). 
Potassium-chloride (KCl) and Triton-X were purchased from Spektrum 3D (Budapest, Hungary, 
from 2008: part of VWR), disodium-sulfate (Na2SO4) from Fine Chemical Co. (Budapest, Hungary) 
and magnesium-chloride hydrate (MgCl2*6 H2O) from Scharlau (Barcelona, Spain). 
  
2.2. Animals 
For this study C57Bl/6 female and male mice were used. The animals were housed under standard 
laboratory conditions (50% ± 2% humidity, 22°C ± 1°C temperature range and 12h - 12h light - 
dark cycle) in cages (max 4 per cage) with free access to food (standard rodent diet) and drinking 
water. We examined 6 groups of animals consisting of 6, 16 and 66 weeks old male and female 
mice (n = 9 in each group). All animal experiments were carried out in accordance with the 
Scientific Ethics Committee for Animal Research of the Protection of Animals Advisory Board 
(XXIV./352/2012.). 
 
2.3. Sample preparation 
At the age of 6, 16 and 66 weeks, the animals were deeply anesthetized with isoflurane (Forane®; 
Abott Laboratories Hungary Ltd., Budapest, Hungary). After thoracotomy, venous blood was 
collected from the right ventricle by intracardial puncture into Eppendorf tubes containing EDTA, 
followed by perfusion with artificial cerebrospinal fluid (pH = 7.4, composition in mM: 122 NaCl, 
3 KCl, 1 Na2SO4, 1.25 KH2PO4, 10 D-glucose*1 H2O, 1 MgCl2*6 H2O, 2 CaCl2*2 H2O, 6 
NaHCO3) for 5 min by an automatic peristaltic pump. After centrifugation of blood samples at 4°C 
for 5 min at 3500 RPM, the supernatant plasma (200 µL) were mixed immediately with 200 µL 85 
mM ascorbic acid and 400 µL 1.14 mM BHT-EtOH solution and the samples were stored at -80°C 
until further use. Before measurements, 600 μL n-hexane containing 1.14 mM BHT and rT, as 
internal standard (IS), was added to the stabilized and freshly thawed plasma samples. After an 
intensive 1 minute long vortex, the samples were centrifuged at 4°C for 10 min at 12000 RPM. In 
the next step, 450 µL of the hexane layer was evaporated under nitrogen flow. The residue was 
resolved with 75 μL ACN and 50 μL EtOH–dioxane (1:1), then placed into amber-coloured HPLC 
vials for measurements. 
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The anatomical borders of 5 different brain regions (striatum, cortex, hippocampus, cerebellum and 
brainstem) were determined with the aid of the online-available Allen Brain Atlas: Mouse Brain 
(Allen Institute for Brain Science, Seattle, WA, USA; http://mouse.brain-map.org/static/atlas), and 
they were rapidly removed on ice and stored at -80°C until further use. Before measurements, the 
samples were weighed and sonicated (UP100H, Hielscher Ultrasound Technology, Germany; 
amplitude: 100%, cycle: 0.5) in 1020 µL ice-cold solution (composition in mM: 75 Na2HPO4*2 
H2O, 17 NaH2PO4, 121 NaCl, 2 KCl, 1 EDTA, 67 ascorbic acid, 2 BHT and 0.2 v/v% Triton-X, 9.8 
v/v% EtOH). The samples were centrifuged next at 4°C for 10 min at 12000 RPM, and the 
supernatants were collected and stabilized applying the same method as described in case of the 
plasma. 
 
2.4. Chromatographic conditions 
The concentrations of the β/γT and δT were under the limit of detection in cases of all 
measurements with all the applied detectors, only αT levels could be quantified, so we focus on this 
compound in the following part of the methodological description. For the quantification of αT and 
the IS (rT) from the mouse plasma samples, a previously published method of the authors was 
utilized [12], with the slight modification that the chromatographic separations were performed on a 
Kinetex C18 column, 150 × 4.6 mm i.d., 5 μm particle size (Phenomenex Inc.,Torrance, CA, 
USA ). 
Two independent methods, utilizing ECD and FLD, were developed for the quantification of αT 
from certain different brain regions, also with the application of rT as an IS. Both methods involved 
the utilization of an Agilent 1100 HPLC system (Agilent Technologies, Santa Clara, CA, USA) 
equipped with a Model 105 ECD (Precision Instruments, Marseille, France) and a FLD (Agilent 
Technologies, Santa Clara, CA, USA). Measurements were carried out under isocratic conditions. 
The first step of our ECD method development was the determination of the optimal working 
potential for αT and rT. As a result of our measurements (Fig. 1) the working potential was set at 
+700 mV, using a glassy carbon electrode and an Ag/AgCl reference electrode. 
The mobile phase consisted of 91.25 v/v% MeOH, 4.25 v/v % distilled water, 4.5 v/v % IPA and 
2.81 w/v% NaClO4 and it was delivered at a rate of 1.2 ml/min at 25°C onto the reversed-phase 
column (Luna C18, 75 x 4.6 mm, 3 µm particle size, Phenomenex Inc., Torrance, CA, USA) after 
passage through a pre-column (SecurityGuard, 4 x 3.0 mm i.d., Phenomenex Inc., Torrance, CA, 
USA). 10 µL of aliquots were injected by the autosampler with the cooling module set at 4°C. 
For the method, using FLD detection, the mobile phase consisted of pure methanol, applying the 
slightly modified method of Yuan et al. [34]. The flow rate was 1.8 ml/min at 25°C, using the same 
column as in the ECD method. The excitation and emission wavelengths were set at 292 nm and 
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330 nm, respectively, for the determination of both αT and rT based on spectral analysis. The 
injection volume was 10 µL, and the samples were thermostated at 4°C. For ECD and FLD, 2 
parallel measurements were carried out for each sample. 
 
2.5. Validation of the applied methods 
2.5.1. Calibration curve and linearity 
In case of DAD measurements, calibrators were prepared in 1.14 mM BHT-EtOH, then they were 
arranged in six different concentration levels with concentration ranges of 1 – 50 μM and 0.25 – 
12.5 μM for αT and rT, respectively. In case of ECD measurements, these ranges were the 
following: 0.05 − 2.0 μM and 0.30 − 6.0 μM for αT and rT, respectively, whereas in case of FLD 
measurements, the concentration levels were similarly between 0.10 − 2.0 μM and 0.30 − 6.0 μM 
for αT and rT, respectively. The peak area responses were plotted as a function of the corresponding 
concentration and linear regression computations were evaluated by the least square method with 
the freely available R software [35]. Good linearity (R2 ≥ 0.99) was detected in each method 
throughout the concentration ranges for all compounds. 
 
2.5.2. Selectivity 
To analyze the selectivity of the methods, we matched the chromatograms of αT and rT for a blank 
plasma or central nervous system (CNS) sample and those for a spiked sample. As shown in Fig. 2, 
both compounds can be detected without interference from other compounds. 
 
2.5.3. Precision 
With regard to the within-run precision, the coefficients of variation of the concentrations were 
0.73%, 1.49% and 3.46% for αT and 0.62%, 1.84% and 0.75% for rT in case of DAD, ECD and 
FLD, respectively.  
 
2.5.4. Recovery 
The relative recoveries were estimated by measuring spiked samples of αT at two different 
concentration levels with three replicates of each. No significant differences were observed for the 
lower and higher concentrations. The recoveries for the plasma samples ranged from 67% to 71% 
with DAD, whereas the recoveries for brain samples ranged from 104% to 106% in case of ECD 
and 87% to 104% with FLD. 
 
2.5.5. Limit of detection (LOD) and limit of quantification (LOQ) 
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Regarding the quantitative analysis, both LOD and LOQ are important parameters, LOD showing 
the smallest concentration that can be detected, but not necessarily quantified, whereas LOQ is the 
lowest analyte concentration in a sample that can be measured with an acceptable level of accuracy 
and precision [36, 37]. In the current study, LOD and LOQ were calculated as shown in Equation 1. 
The LOD values for αT were the following: 397 nM, 26 nM and 41 nM for DAD, ECD and FLD, 
respectively. The LOQ values for αT were 1202 nM, 77 nM and 123 nM for DAD, ECD and FLD, 
respectively. 
 
Equation 1 
The calculation of LOD and LOQ values by formula, where σ is the standard error of the intercept 
and S’ is the slope of the calibration curve of the analyte. LOD limit of detection; LOQ limit of 
quantification. 
 
2.5.6. Statistical analysis 
All statistical calculations were performed with the use of the freely available R software [35]. We 
first checked the distribution of data populations with the Shapiro-Wilk test, and we also performed 
the Levene test to confirm the homogeneity of variances. As the distribution proved to be Gaussian 
and the variances were equal, two-way ANOVA was applied with Tukey HSD post hoc test for 
pairwise comparison. We decided a priori that the comparisons of opposite gender and age groups 
may not yield meaningful information, so they were not implemented, therefore only 9 comparisons 
were applied between the 6 groups. We rejected the null hypothesis when the p-values were ≤ 0.05, 
and in such cases the differences were considered significant. If any significant change was 
observed, the effect size was calculated (omega-squared (ω2) for two-way ANOVA and Cohen’s d 
for Tukey HSD) [38, 39]. Data were plotted as means (± S.D.). 
 
3. Results 
3.1. Plasma 
The results of the measurements of αT concentration from plasma samples are presented in Table 1, 
2 and 3, and in Fig. 3a. The applied two-way ANOVA demonstrated significant difference for age 
(F = 10.55, df = 2, p < 0.001, ω2 = 0.0276) but no differences for gender (F = 0.64, df = 1, p = 
0.427) or age vs. gender (F = 1.11, df = 2, p = 0.339). Post hoc analysis with Tukey HSD test 
yielded a significant increase in αT concentrations with aging only between 16 and 66 weeks old 
male mice (p < 0.01; Table 2), with a 2.234 effect size (Table 3). 
 9 
 
 
3.2. Brain regions 
The measurements of αT concentration from brain samples are demonstrated in Table 1, 2 and 3, 
and Fig. 3b-f. In light of the validation parameters, both ECD and FLD measurement are applicable 
for the determination of αT from brain samples and accordingly, the results of FLD and ECD 
measurements were averaged for each individual CNS sample. In the next step, the implementation 
of two-way ANOVA with Tukey HSD post hoc test yielded the following results. 
In the striatum (Fig. 3b), there was a significant difference for age (F = 120.019, df = 2, p < 0.001, 
ω2 = 0.0752) and gender (F = 23.062, df = 1, p < 0.001, ω2 = 0.0070), and for age vs. gender (F = 
3.588, df = 2, p = 0.0353, ω2 = 0.0016) as well. The Tukey HSD post hoc test revealed significantly 
elevated αT concentrations in the latter groups in the following pairwise comparisons from those of 
a priori decided: p < 0.001 for 6 vs. 16 weeks old females and p < 0.01 for males; p < 0.001 for 
both 16 vs. 66 weeks old females and males; p < 0.001 for both 6 vs. 66 weeks old females and 
males; p < 0.05 for 16 weeks old males vs. females and p < 0.001 for 66 weeks old males vs. 
females (Table 1 and 2). 
In the cortex (Fig. 3c), there was also a significant difference for age (F = 159.589, df = 2, p < 
0.001, ω2 = 0.1042), gender (F = 17.377, df = 1, p < 0.001, ω2 = 0.0054), and for age vs. gender (F 
= 5.465, df = 2, p = 0.0073, ω2 = 0.0029). The Tukey HSD post hoc test revealed significantly 
elevated αT concentrations in the latter groups in the following pairwise comparisons from those of 
a priori decided: p < 0.001 for 6 vs. 16 weeks old females and p < 0.05 for males; p < 0.001 for 
both 16 vs. 66 weeks old females and males; p < 0.001 for both 6 vs. 66 weeks old females and 
males and p < 0.001 for 66 weeks old males vs. females (Table 1 and 2). 
Furthermore, in the hippocampus (Fig. 3d), similar results were demonstrated for age (F = 195.500, 
df = 2, p < 0.001, ω2 = 0.1056), gender (F = 24.343, df = 1, p < 0.001, ω2 = 0.0063), and for age vs. 
gender (F = 7.045, df = 2, p = 0.0021, ω2 = 0.0033). The Tukey HSD post hoc test revealed 
significantly elevated αT concentrations in the latter groups in the following pairwise comparisons 
from those of a priori decided: p < 0.001 for both 6 vs. 16 weeks old females and males; p < 0.001 
for both 16 vs. 66 weeks old females and males; p < 0.001 for both 6 vs. 66 weeks old females and 
males and p < 0.001 for 66 weeks old males vs. females (Table 1 and 2). 
With regard to the cerebellum (Fig. 3e) and the brainstem (Fig. 3f), there was a significant 
difference for age (F = 17.091, df = 2, p < 0.001, ω2 = 0.0134 and F = 3.491, df = 2, p =0.0384, ω2 = 
0.0021, respectively) and gender (F = 10.66, df = 1, p = 0 0020, ω2 = 0.0040 and F = 13.295, df = 1, 
p < 0.001, ω2 = 0.0051, respectively), but not for age vs. gender (F = 2.897, df = 2, p = 0.0649 and F 
= 0.820, df = 2, p = 0.4464, respectively). The Tukey HSD post hoc test revealed significantly 
elevated αT concentrations only in case of the cerebellum in the latter groups in the following 
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pairwise comparisons from those of a priori decided: p < 0.01 for 6 vs. 16 weeks old females and p 
< 0.001 for 6 vs. 66 weeks old females (Table 1 and 2). 
The corresponding effect size values for the significant differences in brain αT concentrations are 
presented in Table 3. 
 
4. Discussion 
 
Evidence suggests that tocopherols may have a special role in antioxidant protection in lipid-rich 
structures, such as the CNS. As there is a clear worsening of brain functioning with aging, there 
were several approaches which aimed at the achievement of neuroprotection via the administration 
of exogenous αT [40–44]. However, only limited data are available on the changes of endogenous 
tocopherol levels either in human or murine brain samples with aging [12, 13, 17, 18, 28]. 
Therefore, there is a special need for the fine assessment of age-related changes in αT levels. The 
identification of clear trends with regard to either certain brain regions or genders may help to 
understand the differences in the sensitivity to oxidative damage. Although the main focus may be 
paid on human studies, the assessment of rodents from this point of view may also yield relevant 
information in light of the fact that most preclinical research on neurodegeneration is carried out in 
animals belonging to this subfamily. 
Accordingly, the aim of the current study was to determine region-, age- and gender-specific 
changes in brain αT level in the C57Bl/6 mouse strain, which is one of the most commonly applied 
strains in the research on neurodegeneration. Furthermore, our study was supplemented with the 
assessment of plasma samples as well to be able the judge the possible influence of peripheral 
changes on brain αT levels. The results demonstrated that brain αT levels significantly increased in 
the striatum, cortex, and hippocampus with aging in both genders. This increase was more 
pronounced in females and the magnitude of this difference also rose with aging in case of all the 
above-mentioned brain regions. However, in case of the cerebellum, a moderate elevation could be 
detected only in females, whereas in case of the brainstem there was no significant change in αT 
level. With regard to plasma samples, no clear trend could be identified, a significant difference was 
found only between 16 and 66 weeks old males. These findings are in line with those found by 
Takahashi et al. [28] and Gohil et al. [27], i.e., there is a clear elevation of cortical and hippocampal 
αT levels, but only a moderate increase in cerebellar αT level with aging and significantly higher 
values in females. The novelty of the current study is the presentation of such a pronounced 
elevation in striatal αT level, while no change in brainstem αT level, and furthermore, the first 
delineation that the difference between genders significantly increases with aging in case of the 
striatum, cortex and hippocampus. Similar to that found by Takahashi et al., plasma αT level 
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seemingly does not influence the characteristic change in striatal, cortical and hippocampal αT 
levels. In addition to the clear and unbiased demonstration of region-, age- and gender-specific 
changes in mouse brain αT level via the application of different validated HPLC methods, this 
article also aims at highlighting the possible underlying factors behind these findings and their 
hypothetic significance as well. 
For better understanding of these results, we looked further into the transport and metabolism of 
tocopherols. The transport of vitamin E in the mammalian body is well documented [45–47]. Due to 
the chemical properties of vitamin E compounds, their circulation is associated with lipoproteins, 
but their transcellular transport is mediated by carrier proteins [45]. The major forms of vitamin E, 
αT and γT are taken up by diet and absorbed from the small intestine, followed by their 
transportation to the liver by chylomicrons. In hepatocytes, a special binding protein, αT transport 
protein (α-TTP), is expressed and has a major role in αT uptake. Studies have shown that α-TTP 
recognizes preferably αT by its chemical characters [45]. From liver cells, αT is transferred to the 
serum by very-low density lipoproteins (VLDL). Following the hydrolysation of VLDL by plasma 
enzymes to low-density lipoprotein (LDL), it delivers αT to extrahepatic tissues via the LDL 
receptor-mediated pathway [47, 48].  
In the brain the CSF has an important role in micronutrient distribution, including vitamins as well 
[46]. The transportation of vitamins B1, B3 and E from blood to CSF with simple diffusion cannot 
provide enough concentrations for tissue cells, therefore several specific systems (facilitated 
diffusion, active sodium-dependent or independent systems, receptor related systems and many 
other mechanisms) are included as well [46, 49]. Accordingly, it was proposed that brain αT 
homeostasis has a strict regulation, but the precise description of the pharmacokinetics of vitamin E 
transport into the CSF and brain is not available yet, although some possible mechanisms were 
previously described in the literature [46]. 
One of these mechanisms may be connected to the scavenger receptor class B type 1 (SR-B1) [50–
52], which is responsible for αT transport across the blood-brain barrier (BBB) by promoting the 
uptake of HDL-associated αT in brain capillary endothelial cells (BCEC). Balázs et al. [50] 
proposed that SR-B1 is located at the caveolae of the apical membrane of BCEC and facilitates the 
selective uptake of HDL-associated αT by transcytosis across the BBB. In the study of Srivastava et 
al. [51], C57Bl/6 mice were fed with high-cholesterol and high-fat containing diet and their brain 
SR-B1 expressions consequently increased, although hepatic SR-B1 expression was not influenced. 
Furthermore, Mardones et al. [52] demonstrated that SR-B1 knock-out (KO) female and male (n = 
3-6, 2 - 4 months old) mice have significantly higher plasma and lower CNS αT levels, consistent 
with the postulated role of SR-B1 at the BBB. Surprisingly, the whole brain levels were not 
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decreased enough to cause deficiency symptoms. There are no available data on the influence of 
aging and gender on SR-B1 expression. 
The second possible mechanism may be connected to phospholipid transfer protein (PLTP) [53]. 
PLTP is highly expressed in the choroid plexus (CP) which raises the possibility that PLTP is 
involved in the transfer of αT from plasma into the CSF [54, 55]. In PLTP KO female mice (n = 6) 
Desrumaux et al. [54] investigated the brain concentration of αT and found it decreased by 30% 
compared to controls and found considerably higher (by 450%) lipofuscin level, which is the final 
product of the reaction of lipid peroxide with proteins during oxidative stress. In the substantia 
nigra. PLTP deficiency also resulted in the accumulation of brain cholesterol derivatives oxidized at 
position 7 and besides this, Yokota et al. [56] proved that lipofuscin accumulations could disappear 
with the application of vitamin E dietary supplementation. Similar to SR-B1, there are also no 
available data on the influence of aging and gender on PLTP expression. 
α-TTP serves as a third mechanism of αT transport in the mammalian brain [56]. The presence of 
this protein is demonstrated in rodent and human brains as well, although the expression level in 
normal brain tissue is low [57]. In α-TTP KO female and male mice (n = 2 – 2), the plasma and 
tissue concentrations were less than 0.46 μM and 0.23 nmol/g ww, respectively. Moreover, 
supplementation with oral vitamin E raised the plasma concentration of these mice close to normal 
(~ 3.4 μM), but the brain levels increased only with ~ 20%, however, this small increase in the brain 
could eliminate the neurological signs [56]. Gohil et al. [27] also investigated α-TTP expression in 
several CNS and liver tissue samples of 5 months old α-TTP KO and control mice with the finding 
that α-TTP protein or its mRNA could only be detected from the liver of controls. Later, Takahashi 
et al. [28] successfully determined α-TTP expressions from the cerebrum, hippocampus and 
cerebellum. However, they utilized only 12-month-old male mice for that purpose, therefore the 
effect of aging and gender could not be analysed. 
Another investigated pathway is in relation with afamin, a member of the albumin super family and 
may serve as a transport protein involved in αT homeostasis as well [58]. Afamin is synthesized 
endogenously by BCEC and assists αT transport to astrocytoma cells, but to a lesser extent than 
HDL-mediated transport. The expression of afamin was detected by immunohistochemistry in 
porcine, mouse and post mortem human brains. It was also demonstrated that afamin level 
correlates with the concentration of αT in the CSF, but not with αT level in the serum [58, 59]. 
However, there are no available data on the influence of aging and gender on afamin expression. 
Although the above-mentioned findings may support the role of SR-B1, PLTP, α-TTP and afamin 
in the transport and regulation of the αT levels in the CNS, the assessment of the effect of aging and 
gender on these transport processes warrants further studies. 
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Probably the major significance of the current findings is that the elevations of αT concentrations by 
aging may serve as to compensate the burden of oxidative stress which increases with aging [12, 43, 
60]. Furthermore, the demonstrated gender-related differences, i.e., significantly higher αT levels in 
female striatal, cortical and hippocampal brain regions, may at least partially explain the decreased 
vulnerability of e.g., C57Bl/6 female mice to certain neurotoxins, e.g., 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine [61–64] compared to the male ones. 
In light of the fact that there are only limited and contradictory data are available on the changes of 
human brain tocopherol levels with aging, the human relevance of the current findings cannot be 
determined at present. However, the results may draw attention to the importance of antioxidant 
protection against oxidative damage, the extent of which clearly increases with aging. With regard 
to the effect of gender on age-related pathological alterations, several human studies were published 
[65–68]. Király et al. [68] demonstrated that male brain ages faster, following the assessment of the 
volume of cortical and subcortical grey matter, including that of the hippocampus, putamen and 
caudate nucleus, within the age-range of 21 to 58 years. Although the age range is presumably 
different, this male preponderance was not reassured in the most common neurodegenerative 
disorder, AD [69], but was proposed in the second most common neurodegenerative disorder, PD 
[70]. Nevertheless, the fact that there is not enough human data to be able to determine the extent of 
the influence of the alterations in tocopherol homeostasis on the pathogenetic process in major age-
related neurodegenerative disorders, warrants further studies. 
In conclusion the current study is the first to demonstrate age-dependent gender-specific changes in 
αT level in certain brain regions of the C57Bl/6 mouse strain which finding may explain the 
increased vulnerability of male C57Bl/6 mice to certain neurotoxins targeting these regions, but the 
delineation of possible underlying mechanisms and the demonstration of their human relevance may 
require future studies. Nevertheless, a deeper insight into this aspect of antioxidant protection may 
help the development of therapeutic strategies against age-related pathogenetic processes. 
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8. Figure captions 
Fig. 1 
Plotted peak areas vs. voltage diagram of αT and rT. αT α-tocopherol; rT rac-tocol. 
 
Fig. 2 
Representative chromatograms of rT and αT. The chromatograms of blank and spiked (with rT and 
αT) mouse plasma samples measured with DAD (a) and those of blank and spiked (with rT and αT) 
mouse brain sample homogenizations measured with ECD (b) and FLD (c) are demonstrated. αT α-
tocopherol; DAD diode-array detector; ECD electrochemical detector; FLD fluorescence detector; 
rT rac-tocol. 
 
Fig. 3 
αT concentration levels in plasma and in different brain regions of mice. We observed significant 
elevation of αT levels in the plasma (a), striatum (b), cortex (c), hippocampus (d) and cerebellum 
(e), but not in the brainstem (f) with aging. To avoid the overcomplication of this figure, the results 
of statistical comparisons are presented elsewhere (Table 1, 2 and 3), except that for the interaction 
which may help in the interpretation of the presence or absence of increasing difference between 
males and females with aging. Data are presented as mean (± S.D.); n = 9; αT α-tocopherol; N.S. not 
significant. 
